1 Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain.
2 Cancer Evolution and Genome Instability Laboratory, University College of London Cancer Institute, London, UK.
3 Department of Medical Oncology, Biomedical Research Institute INCLIVA, University of Valencia, Valencia; CIBERONC, Instituto de Salud Carlos III, Madrid, Spain. Electronic address: andres.cervantes@uv.es.